Timothy Keaney

About Timothy Keaney

Independent Chair of the Board at AlTi Global, Inc. (ALTI). Age 63; joined the ALTI Board in January 2023. Former Vice Chairman and senior operating executive at BNY Mellon, with deep asset servicing and investment services leadership; holds a B.S.B.A. from Babson College. The Board separates the Chair and CEO roles, with Keaney as independent Chair and Michael Tiedemann as CEO, a structure ALTI views as appropriate for risk oversight and management focus .

Past Roles

External Roles

Board Governance

• Board leadership: Independent Chair (Keaney) and separate CEO role; Board emphasizes risk oversight via committees .
• Independence: Board determined Keaney is independent under Nasdaq and SEC rules .
• Committee memberships and expertise:
  • Audit Committee member; qualifies as “audit committee financial expert” under Item 407 of Regulation S-K .
  • ESG&N Committee member .
• Committee chairs (for context): Audit Committee chaired by Mark Furlong; Compensation Committee chaired by Norma Corio; ESG&N Committee chaired by Tracey Brophy Warson; Transaction Committee chaired by Mark Furlong .
• Board and committee activity:
  • Board met 14 times in FY2024; all directors attended at least 75% of Board and applicable committee meetings .
  • Committee meetings in 2024: Audit 13; Compensation 9; ESG&N 4; Transaction 1 .
• Policies:
  • Prohibition on hedging/pledging ALTI securities by directors and insiders .
  • Related party transaction policy requiring Audit Committee review/approval of Item 404 transactions .
  • Clawback policy for incentive-based compensation in event of a material restatement (executives) .
  • As an emerging growth company, ALTI is not required to hold say‑on‑pay votes .

Fixed Compensation

• Director cash retainer framework (non-employee): Board Chair $40,000; Board Member $100,000; Audit Committee Chair/Member $20,000/$10,000; Compensation $10,000/$5,000; ESG&N $10,000/$5,000; Transaction $10,000/$5,000. Equity grants typically ~ $110,000 in value and vest by the next annual meeting or June 30 of the following year .
• Non-employee director annual total compensation limit in the Amended 2023 Plan: $500,000, with extraordinary exceptions requiring recusal .

Performance Compensation

• Director equity grants are time-based RSUs; no disclosed director performance-linked metrics (e.g., TSR or financial targets) in director pay. Executive PSUs exist but are not applicable to Keaney’s director compensation .

Other Directorships & Interlocks

• ALTI disclosed extensive investor rights agreements (Allianz, Constellation) and a Tax Receivable Agreement with certain members of legacy entities including certain directors/officers; specific inclusion of Keaney is not stated. Audit Committee oversees related party transactions per policy .

Expertise & Qualifications

• Audit and finance: Qualified “audit committee financial expert”; long-tenured audit chair at Unum; extensive risk management oversight .
• Asset servicing/operations: Led global asset servicing and investment services businesses at BNY Mellon; cross-border operational leadership .
• Wealth and asset management: Career experience aligns with ALTI’s core business; governance and strategic oversight capabilities .
• Education: B.S.B.A., Babson College .

Equity Ownership

• Hedging/pledging: Prohibited under ALTI’s insider trading policy .

Governance Assessment

• Strengths

  • Independent Chair structure enhances oversight; Keaney’s audit/finance expertise and designation as financial expert bolster financial reporting integrity .
  • Active committee engagement and robust meeting cadence (Board 14; Audit 13) support board effectiveness; attendance at or above 75% minimum for all directors .
  • Clear guardrails: anti-hedging/pledging; related-party transaction review by Audit Committee; clawback policy for executives .

• Alignment and incentives

  • Director pay includes meaningful equity via RSUs; Keaney’s 2024 mix (~68% equity by grant-date FV) aligns interests but is time-based rather than performance-linked, common for directors .

• Potential risks/considerations

  • As an emerging growth company, absence of say‑on‑pay reduces shareholder advisory feedback on pay practices; ongoing vigilance on equity plan dilution is warranted given requested increase to 20.81 million shares under the Amended Plan .
  • Complex capital structure (Series A and C Preferred, warrants, TRA) introduces multi-stakeholder dynamics; while no specific conflicts tied to Keaney are disclosed, continued scrutiny of related-party review processes is appropriate .

• Red flags

  • No Section 16(a) delinquency disclosures naming Keaney for 2024; late filings were noted for other individuals and a 10% holder .
  • No disclosures of pledging, hedging, or related-party transactions involving Keaney; policy prohibitions reduce risk .

Overall, Keaney’s independent chairmanship, audit expertise, and cross-industry governance experience support investor confidence in board oversight and financial governance at ALTI. Monitoring equity plan usage and the governance of investor rights agreements remains prudent as ALTI scales .